
National Association of Testing Authorities, Australia
Scope of Accreditation
Bay Medical Group
Scope of Accreditation
Withdrawn
Salamander Medical Centre
ISO 15189 (2012)
Human Pathology
Medicare expiry date
14 Oct 2022
Last Activity Date
26 Nov 2019
|
||
Service | Product | Determinant |
---|---|---|
Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma | HDL - Quantitation |
Chemical pathology - Further investigation of renal and/or hepatic function | Blood; Plasma; Serum | Uric acid |
Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood; Plasma; Serum | Cholesterol - Total; Glucose; Triglycerides |
Urine | Creatinine; Microalbumin | |
Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | International normalised ratio (INR) |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
3446
Site No.
3439
Print date
06 Dec 2023
END OF SCOPE